p53 Mutation in Nonmelanoma Skin Cancers Occurring in Psoralen Ultraviolet A-Treated Patients: Evidence for Heterogeneity and Field Cancerization
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (2) , 522-526
- https://doi.org/10.1046/j.1523-1747.2002.01814.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Induction and Excretion of Ultraviolet-Induced 8-Oxo-2′-deoxyguanosine and Thymine Dimers In Vivo: Implications for PUVAJournal of Investigative Dermatology, 2001
- PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2′-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cellsFree Radical Biology & Medicine, 1999
- Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: The role of molecular epidemiology in minimizing risksEnvironmental and Molecular Mutagenesis, 1998
- Molecular support for field cancerization in the head and neckCancer, 1998
- Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residuesNature, 1987
- Neoplastic Transformation of C3H Mouse Embryo 10T1/2 Cells by 8-Methoxypsoralen Plus UVA RadiationJournal of Investigative Dermatology, 1985
- Systemic suppression of contact hypersensitivity by ultraviolet b radiation or methoxsalen/ultraviolet a radiation in the guinea PigCellular Immunology, 1984
- Systemic Suppression of Contact Hypersensitivity in Mice by Psoralen Plus UVA Radiation (PUVA)Journal of Investigative Dermatology, 1983
- Photochemotherapy of PsoriasisNew England Journal of Medicine, 1974
- DNA cross-linking in chinese hamster cells exposed to near ultraviolet light in the presence of 4,5′,8-trimethylpsoralenBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1973